Your browser doesn't support javascript.
loading
HER2-positive breast cancer progresses rapidly after pyrotinib resistance: acquired RET gene fusion and TP53 gene mutation are potential reasons.
Jiang, Fengxian; Lai, Jingjiang; Zhuo, Xiaoli; Liu, Lei; Yang, Yucheng; Zhang, Junlei; Zhao, Jing; Xu, Wei; Wang, Jingliang; Wang, Cuiyan; Fu, Guobin.
Afiliación
  • Jiang F; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University.
  • Lai J; The Second Clinical Medical College, Shandong University of Traditional Chinese Medicine.
  • Zhuo X; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University.
  • Liu L; The Second Clinical Medical College, Shandong University of Traditional Chinese Medicine.
  • Yang Y; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University.
  • Zhang J; The Clinical Medical College, Shandong First Medical University (Shandong Academy of Medicine).
  • Zhao J; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University.
  • Xu W; The Clinical Medical College, Shandong First Medical University (Shandong Academy of Medicine).
  • Wang J; Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University.
  • Wang C; Department of Pathology.
  • Fu G; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University.
Anticancer Drugs ; 34(10): 1196-1201, 2023 11 01.
Article en En | MEDLINE | ID: mdl-36689646
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans / Middle aged Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans / Middle aged Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2023 Tipo del documento: Article